Please try another search
Frontier Biotechnologies Inc., a commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patients’ health in China. It offers Aikening, a long-acting HIV fusion inhibitor for the treatment of HIV infection and AIDS. The company’s products under development include small RNA drugs, such as FB7011/FB7013/FB7014 to treat IgA nephropathy, FB7022/FB7021 for dyslipidemia, and FB7012/FB7041/FB7031/FB7032 for various other diseases, including hyperuricemia and gout, tumors, and metabolic-associated fatty liver diseases; FB4001, to treat patients with osteoporosis or high risk of fracture; and FB3002, for the treatment of pain in muscles, bones, and joints. Frontier Biotechnologies Inc. was founded in 2002 and is headquartered in Nanjing, China.
| Name | Age | Since | Title |
|---|---|---|---|
| Changjin Wang | 67 | 2013 | MD, CBO & Director |
| Dong Xie | 59 | 2002 | Founder, Chairman, President & Chief Scientific Officer |
| Rongjian Lu | 63 | 2013 | CTO & Director |
| Qidong You | 70 | 2024 | Independent Director |
| Yuantao Cao | 44 | 2018 | Supervisor |
| Yuting Zhu | 36 | 2019 | Supervisor & Deputy GM of Administration |
| Zhi Zhong Jiang | 43 | 2016 | Chairman of the Supervisory Board & Purchasing Director |
| Yuanfan Chen | 39 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review